Authors
Latest:
Artificial DMEK could help tackle endothelial donor tissue shortageNew acrylic implant provides option for patients with endothelial dysfunction.
Latest:
Topical presbyopic correction: a postoperative problem solverPresbyopia-correcting drops represent a whole new product category—one with a lot of upsides for clinicians who want to help their patients see well at all distances.
Latest:
Should nonclinicians inject dexamethasone implants?Studies on nurse-led services find a low level of complications among patients.
Latest:
Advantages of incorporating ECP into the surgeon’s armamentariumShort learning curve, significant clinical advantages make this a comfortable addition.
Latest:
What ophthalmologists need to know about neuromyelitis optica spectrum disorderEarly diagnosis of NMOSD is key to preventing disability, improving survival.
Latest:
Clearing hurdles to large scale telemedicine adoptionDuring the COVID-19 pandemic, it is important to develop technologies to keep patients and staff safe, while treating the diseases of the eye
Latest:
ACHIEVING IMPROVED OUTCOMES THROUGH PARTNERSHIPS BETWEEN OPTOMETRISTS AND RETINA SPECIALISTSConsiderations in the treatment of diabetic retinopathy and diabetic macular edema.
Latest:
Welcome to the metaverse: Technology allows ophthalmologists to mingle with colleagues worldwideAnswers to common questions that can help kick-start the journey into the metaverse to learn from the many virtual educational meetings and conference opportunities while mingling with colleagues worldwide.
Latest:
ARVO 2025: Inflammatory eye disorders in hidradenitis suppurativa patientsAt ARVO 2025, in Salt Lake City, Utah, Anisha Kasi talked about her presentation on how her team used the TriNetX database, a large database of over 150 million patients worldwide, to validate the connection between hidradenitis suppurativa and inflammatory eye conditions.
Latest:
ARVO 2025: First in-human clinical trials results from magnetic cell therapyEllen Koo, MD, presented data from first in-human clinical trials, looking at the results from magnetic cell therapy and reports on the efficacy and safety in the patients.
Latest:
Long-Term Outcomes After Nonimplant MIGS ProcedureA panelist discusses how nonimplant MIGS, such as viscocanaloplasty and viscoelastic delivery devices, offer long-term IOP reduction and medication savings, emphasizing their benefits for early intervention and improved postoperative quality of life, while noting limitations for more advanced glaucoma conditions.
Latest:
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San FranciscoThe 14th annual Glaucoma 360 conference, co-founded by Adrienne Graves, PhD, and Andrew Iwach, MD, and hosted by Glaucoma Research Foundation, will be held from February 6-8, 2025, at the Westin St. Francis in San Francisco, California. The event will focus on the latest advancements in glaucoma care and encourage innovation and collaboration.
Latest:
Monitor keratoconus progression after cross-linking treatmentContemporary scleral lenses work so well that stable vision in them cannot necessarily be taken as a sign that KC progression has stopped. Determination of KC progression requires advanced imaging.
Latest:
ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery mattersA significant proportion of cataract surgery patients exhibit hyperosmolar tear film both before and 1 month after surgery, underscoring preoperative screening and postoperative management to optimize visual outcomes.
Latest:
Cyclosporine drop for treating dry eye offers new advantagesDelivered in a water-free solution, Vevye’s new formulation offers a high concentration of cyclosporine that works rapidly, has no preservatives, and rarely causes irritation
Latest:
One shingle at a time: Starting a solo practiceSometimes, the best job for you is the one you create.
Latest:
Shaffer-Hetherington-Hoskins Lecture at the 2025 Glaucoma 360 meetingM. Roy Wilson, presented the Shaffer-Hetherington-Hoskins Lecture at the Glaucoma 360 meeting held in San Francisco, California. This lecture was entitled, "Rethinking Race as a Risk Factor for Glaucoma: What Really Matters?"
Latest:
IVIg, ICVM may help patients with small fiber neuropathy, neuropathic corneal painNCP should be considered for patients with discomfort, irritation, dryness, grittiness.
Latest:
Robert Maloney, MD, announces retirement from clinical practiceFollowing his keynote address at Controversies in Modern Eye Care, Dr. Maloney said he will be leaving his surgical practice and returning to research.
Latest:
Tuning out anxiety: the role of music in cataract surgeryFrom easing fears to improving mood, a recent study explores how music transforms the surgical experience for both patients and health care teams.
Latest:
Study examines efficiency of physiotherapy in treating, preventing uncomplicated acquired myopiaResearch explores innovative physiotherapeutic approaches to managing myopia progression, showing promising results in slowing its advancement over two years.
Latest:
(Part 2) From ophthalmology’s lockdown to lasting change: The pandemic habits that stuckFrom revised patient flow to smarter tech adoption, ophthalmologists share which changes from 2020 have become cornerstones of modern care—and how they’re preparing for the next big disruption
Latest:
ARVO 2025: PAVIA 12-month results in nonproliferative diabetic retinopathyAt ARVO 2025, in Salt Lake City, Utah, David Almeida, MD, MBA, PhD, talked about 12-month results from the PAVIA phase 2 trial of EYP-1901 in nonproliferative diabetic retinopathy.
Latest:
Q&A: Rachel Downes, MD, provides highlights from the GATHER1 and GATHER2 clinical trials for GADiscover how ellipsoid zone integrity predicts geographic atrophy growth rates in recent clinical trials, enhancing future treatment strategies.
Latest:
The Residency Report: Clinical insights from the iStent infinite trialA conversation with David S. Friedman, MD, PhD, on treating uncontrolled open-angle glaucoma in patients with limited options
Latest:
Welcome to the metaverse: Technology allows ophthalmologists to mingle with colleagues worldwideAnswers to common questions that can help kick-start the journey into the metaverse to learn from the many virtual educational meetings and conference opportunities while mingling with colleagues worldwide.
Latest:
ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practiceMajmudar encourages young surgeons to seek hands-on experience early and often, stressing the importance of real-world practice beyond the classroom.
Latest:
ARVO 2025: Analysis of AREDS oral micronutrient supplementation on geographic atrophy growthAt ARVO 2025, in Salt Lake City, Utah, Roger Goldberg, MD, MBA, talked about his presentation on the effect of AREDS vitamins in geographic atrophy.
Latest:
Mercy Ships delivers a lifeline for eye health in Africa’s remote communitiesThrough its ophthalmic program, Mercy Ships provides critical eye surgeries and trains local professionals, ensuring sustainable eye care for the future.
